Rapport Therapeutics, Inc. Common Stock
RAPPNASDAQHealthcare● Active
$38.11
+$1.43(+3.90%)
Market Cap$1.4B
P/E Ratio—
52W High$42.269
52W Low$10.505
Rapport Therapeutics, Inc. Common Stock (RAPP) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RAPP · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | ($0.11B) | ($0.08B) | ($0.03B) | ($0.01B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Net Cash from Operations | ($0.09B) | ($0.06B) | ($0.03B) | ($0.00B) |
| Investing Activities | ||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | ($0.38B) | ($0.08B) | $0.00B |
| Sales of Investments | $0.00B | $0.21B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.19B) | ($0.17B) | ($0.08B) | ($0.01B) |
| Financing Activities | ||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.01B |
| Net Cash from Financing | $0.27B | $0.22B | $0.15B | $0.04B |
| Free Cash Flow | ||||
| Free Cash Flow | ($0.09B) | ($0.07B) | ($0.03B) | ($0.00B) |
| FCF Margin %(computed) | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Rapport Therapeutics, Inc. Common Stock data
About Rapport Therapeutics, Inc. Common Stock (RAPP) Cash Flow Statement
Rapport Therapeutics, Inc. Common Stock generated operating cash flow of ($0.09B) and free cash flow of ($0.09B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
RAPP · 4 questionsRapport Therapeutics, Inc. Common Stock generated free cash flow of ($0.09B) for 2025, down 31.0% year-over-year.
RAPP free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10